Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bungaro

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Blood Cells, Molecules & Diseases|October 9, 2002
Differences between in vivo and in vitro sensitivity to imatinib of Bcr/Abl+ cells obtained from leukemic patientsCarlo B Gambacorti-Passerini, Francesca Rossi, Magda Verga, et al.
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Performing oncological procedures during COVID-19 outbreak: a picture from an Italian cancer centerMaristella Bungaro, Valentina Bertaglia, Marco Audisio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 7, 2023
Autocrine 17-β-Estradiol/Estrogen Receptor-α Loop Determines the Response to Immune Checkpoint Inhibitors in Non-Small Cell Lung CancerDario P Anobile, Iris C Salaroglio, Fabrizio Tabbò, et al.
Critical Reviews in Oncology/Hematology|December 20, 2020
Italian survey on the clinical management of non-small cell lung cancer patients during the COVID-19 pandemic: A lesson for the second waveValentina Bertaglia, Maria Lucia Reale, Paolo Bironzo, et al.
Plos One|March 23, 2013
The Polo-Like Kinase 1 (PLK1) inhibitor NMS-P937 is effective in a new model of disseminated primary CD56+ acute monoblastic leukaemiaAlessia Casolaro, Josee Golay, Clara Albanese, et al.
Haematologica|March 20, 2016
Mutations of TP53 gene in adult acute lymphoblastic leukemia at diagnosis do not affect the achievement of hematologic response but correlate with early relapse and very poor survivalSilvia Salmoiraghi, Marie Lorena Guinea Montalvo, Greta Ubiali, et al.
BMJ Oncology|January 31, 2025
Time trends in health-related quality of life assessment and reporting within publications of oncology randomised phase III trials: a meta-research studyLaura Marandino, Federica Trastu, Eleonora Ghisoni, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2023
Analysis of the adequacy of control arms in oncology randomised clinical trials published between 2017 and 2021: a meta-research studyAlessandro Rossi, Giacomo Aimar, Marco Audisio, et al.
Frontiers in Oncology|September 25, 2020
SARS-CoV-2 Infection in Cancer Patients: A Picture of an Italian <i>Onco-Covid</i> UnitMaria Lucia Reale, Paolo Bironzo, Valentina Bertaglia, et al.
Critical Reviews in Oncology/Hematology|February 22, 2022
A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesotheliomaMarco Tagliamento, Paolo Bironzo, Hubert Curcio, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Blood Cells, Molecules & Diseases|October 9, 2002
Differences between in vivo and in vitro sensitivity to imatinib of Bcr/Abl+ cells obtained from leukemic patientsCarlo B Gambacorti-Passerini, Francesca Rossi, Magda Verga, et al.
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Performing oncological procedures during COVID-19 outbreak: a picture from an Italian cancer centerMaristella Bungaro, Valentina Bertaglia, Marco Audisio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 7, 2023
Autocrine 17-β-Estradiol/Estrogen Receptor-α Loop Determines the Response to Immune Checkpoint Inhibitors in Non-Small Cell Lung CancerDario P Anobile, Iris C Salaroglio, Fabrizio Tabbò, et al.
Critical Reviews in Oncology/Hematology|December 20, 2020
Italian survey on the clinical management of non-small cell lung cancer patients during the COVID-19 pandemic: A lesson for the second waveValentina Bertaglia, Maria Lucia Reale, Paolo Bironzo, et al.
Plos One|March 23, 2013
The Polo-Like Kinase 1 (PLK1) inhibitor NMS-P937 is effective in a new model of disseminated primary CD56+ acute monoblastic leukaemiaAlessia Casolaro, Josee Golay, Clara Albanese, et al.
Haematologica|March 20, 2016
Mutations of TP53 gene in adult acute lymphoblastic leukemia at diagnosis do not affect the achievement of hematologic response but correlate with early relapse and very poor survivalSilvia Salmoiraghi, Marie Lorena Guinea Montalvo, Greta Ubiali, et al.
BMJ Oncology|January 31, 2025
Time trends in health-related quality of life assessment and reporting within publications of oncology randomised phase III trials: a meta-research studyLaura Marandino, Federica Trastu, Eleonora Ghisoni, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2023
Analysis of the adequacy of control arms in oncology randomised clinical trials published between 2017 and 2021: a meta-research studyAlessandro Rossi, Giacomo Aimar, Marco Audisio, et al.
Frontiers in Oncology|September 25, 2020
SARS-CoV-2 Infection in Cancer Patients: A Picture of an Italian <i>Onco-Covid</i> UnitMaria Lucia Reale, Paolo Bironzo, Valentina Bertaglia, et al.
Critical Reviews in Oncology/Hematology|February 22, 2022
A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesotheliomaMarco Tagliamento, Paolo Bironzo, Hubert Curcio, et al.
Pageof 9